Counterpoint: The Case for Immediate Active Treatment

Active monitoring strategies recently have received attention as possible treatment options for men with low-risk prostate cancer who have a life expectancy of more than 10 years. However, no current criteria sufficiently predict outcomes for individuals with clinically localized disease and an otherwise long life expectancy who undergo either immediate or delayed treatment, or no treatment. This article describes the available evidence regarding treatment outcomes in men with low-risk prostate cancer and presents the case for immediate active treatment.

If the inline PDF is not rendering correctly, you can download the PDF file here.

Correspondence: William J. Catalona, MD, 675 North Saint Clair Street, Suite 20–150, Chicago, IL 60611. E-mail: wcatalona@nmff.org

References

  • 1.

    American Cancer Society. Cancer Facts and Figures 2007. Available at: http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf. Accessed January 28 2007.

    • Search Google Scholar
    • Export Citation
  • 2.

    National Cancer Institute. Surveillance Epidemiology and End Results (SEER) Program. SEER*Stat Database: Incidence - SEER 17 Regs Public-Use Nov 2005 Sub (1973-2003 varying) National Cancer Institute DCCPS Surveillance Research Program Cancer Statistics Branch released April 2006 based on the November 2005 submission. Available at: www.seer.cancer.gov. Accessed August 28 2006.

    • Search Google Scholar
    • Export Citation
  • 3.

    OberaignerWHorningerWKlockerH. Reduction in prostate cancer mortality in Tyrol, Austria, after introduction of prostate-specific antigen testing. Am J Epidemiol2006;164:376384.

    • Search Google Scholar
    • Export Citation
  • 4.

    FreedlandSJKaneCJAmlingCL. Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer. J Urol2006;175:12981302; discussion 1302–1293.

    • Search Google Scholar
    • Export Citation
  • 5.

    ChooRKlotzLDanjouxC. Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol2002;167:16641669.

    • Search Google Scholar
    • Export Citation
  • 6.

    KlotzL. Active surveillance for prostate cancer: for whom?J Clin Oncol2005;23:81658169.

  • 7.

    CarterHBWalshPCLandisPEpsteinJI. Expectant management of nonpalpable prostate cancer with curative intent: preliminary results. J Urol2002;167:12311234.

    • Search Google Scholar
    • Export Citation
  • 8.

    WarlickCTrockBJLandisP. Delayed versus immediate surgical intervention and prostate cancer outcome. J Natl Cancer Inst2006;98:355357.

    • Search Google Scholar
    • Export Citation
  • 9.

    MillerDCGruberSBHollenbeckBK. Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. J Natl Cancer Inst2006;98:11341141.

    • Search Google Scholar
    • Export Citation
  • 10.

    LoebSGonzalezCMRoehlKA. Pathological characteristics of prostate cancer detected through prostate specific antigen based screening. J Urol2006;175:902906.

    • Search Google Scholar
    • Export Citation
  • 11.

    OhoriMWheelerTMDunnJK. The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. J Urol1994;152:17141720.

    • Search Google Scholar
    • Export Citation
  • 12.

    EpsteinJIWalshPCCarmichaelMBrendlerCB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA1994;271:368374.

    • Search Google Scholar
    • Export Citation
  • 13.

    BastianPJMangoldLAEpsteinJIPartinAW. Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysis. Cancer2004;101:20012005.

    • Search Google Scholar
    • Export Citation
  • 14.

    Bill-AxelsonAHolmbergLRuutuM. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med2005;352:19771984.

    • Search Google Scholar
    • Export Citation
  • 15.

    WongYNMitraNHudesG. Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA2006;296:26832693.

    • Search Google Scholar
    • Export Citation

Article Information

PubMed

Google Scholar

Related Articles

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 11 11 5
PDF Downloads 1 1 1
EPUB Downloads 0 0 0